Diarylpentanoid (1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadiene-3-one) (MS13) Exhibits Anti-proliferative, Apoptosis Induction and Anti-migration Properties on Androgen-independent Human Prostate Cancer by Targeting Cell Cycle-Apoptosis and PI3K...

Overview

Journal Front Pharmacol

Date 2021 Aug 9

PMID 34366863

Citations 2

Authors

Nurul Azwa Abd Wahab

Faridah Abas

Iekhsan Othman

Rakesh Naidu

Affiliations

Soon will be listed here.

Abstract

Diarylpentanoids exhibit a high degree of anti-cancer activity and stability over curcumin in prostate cancer cells. Hence, this study aims to investigate the effects of a diarylpentanoid, 1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadiene-3-one (MS13) on cytotoxicity, anti-proliferative, apoptosis-inducing, anti-migration properties, and the underlying molecular mechanisms on treated androgen-independent prostate cancer cells, DU 145 and PC-3. A cell viability assay has shown greater cytotoxicity effects of MS13-treated DU 145 cells (EC 7.57 ± 0.2 µM) and PC-3 cells (EC 7.80 ± 0.7 µM) compared to curcumin (EC: DU 145; 34.25 ± 2.7 µM and PC-3; 27.77 ± 6.4 µM). In addition, MS13 exhibited significant anti-proliferative activity against AIPC cells compared to curcumin in a dose- and time-dependent manner. Morphological observation, increased caspase-3 activity, and reduced Bcl-2 protein levels in these cells indicated that MS13 induces apoptosis in a time- and dose-dependent. Moreover, MS13 effectively inhibited the migration of DU 145 and PC-3 cells. Our results suggest that cell cycle-apoptosis and PI3K pathways were the topmost significant pathways impacted by MS13 activity. Our findings suggest that MS13 may demonstrate the anti-cancer activity by modulating DEGs associated with the cell cycle-apoptosis and PI3K pathways, thus inhibiting cell proliferation and cell migration as well as inducing apoptosis in AIPC cells.

Citing Articles

Practical Preparation of (3)-Hydroxy-5-Phenylpentanoic Acid: Asymmetric Synthesis of ()-Daphneolone and ()-Dihydroyashabushiketol, and Formal Synthesis of (3,5)-Yashabushidiol B.

Nam S, Cho J, Jung S, Lee H, Ryu H, Oh S Int J Mol Sci. 2025; 26(4).

PMID: 40003941 PMC: 11854942. DOI: 10.3390/ijms26041476.

Anti-Cancer Mechanisms of Diarylpentanoid MS17 (1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one) in Human Colon Cancer Cells: A Proteomics Approach.

Hon K, Zainal Abidin S, Abas F, Othman I, Naidu R Int J Mol Sci. 2024; 25(6).

PMID: 38542474 PMC: 10970808. DOI: 10.3390/ijms25063503.

Targeting PI3K/Akt signaling in prostate cancer therapy.

Hashemi M, Taheriazam A, Daneii P, Hassanpour A, Kakavand A, Rezaei S J Cell Commun Signal. 2022; 17(3):423-443.

PMID: 36367667 PMC: 10409967. DOI: 10.1007/s12079-022-00702-1.

References

Qudjani E, Iman M, Davood A, Ramandi M, Shafiee A . Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents. Recent Pat Anticancer Drug Discov. 2016; 11(3):342-51. DOI: 10.2174/1574892811666160420141613. View

Reiss K, Del Valle L, Lassak A, Trojanek J . Nuclear IRS-1 and cancer. J Cell Physiol. 2012; 227(8):2992-3000. PMC: 3615708. DOI: 10.1002/jcp.24019. View

Huang H, Wang Q, Du T, Lin C, Lai Y, Zhu D . Matrine inhibits the progression of prostate cancer by promoting expression of GADD45B. Prostate. 2018; 78(5):327-335. DOI: 10.1002/pros.23469. View

Liang G, Shao L, Wang Y, Zhao C, Chu Y, Xiao J . Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents. Bioorg Med Chem. 2009; 17(6):2623-31. DOI: 10.1016/j.bmc.2008.10.044. View

Banerjee P, Banerjee S, Brown T, Zirkin B . Androgen action in prostate function and disease. Am J Clin Exp Urol. 2018; 6(2):62-77. PMC: 5902724. View

Yang C, Yue J, Sims M, Pfeffer L . The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo. PLoS One. 2013; 8(8):e71130. PMC: 3737134. DOI: 10.1371/journal.pone.0071130. View

Gad S, Ali H, Gaballa R, Abdelsalam R, Zerfaoui M, Ali H . Targeting CDC7 sensitizes resistance melanoma cells to BRAF-specific inhibitor by blocking the CDC7/MCM2-7 pathway. Sci Rep. 2019; 9(1):14197. PMC: 6775054. DOI: 10.1038/s41598-019-50732-w. View

Bicknell K, Coxon C, Brooks G . Can the cardiomyocyte cell cycle be reprogrammed?. J Mol Cell Cardiol. 2007; 42(4):706-21. DOI: 10.1016/j.yjmcc.2007.01.006. View

Guo J, Kleeff J, Li J, Ding J, Hammer J, Zhao Y . Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma. Oncogene. 2004; 23(1):71-81. DOI: 10.1038/sj.onc.1206926. View

10.

Chen W, Wang X, Wu W . Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis. Curr Med Sci. 2018; 38(4):714-720. DOI: 10.1007/s11596-018-1935-9. View

11.

Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E . Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005; 223(2):181-90. DOI: 10.1016/j.canlet.2004.09.041. View

12.

Hata A, Engelman J, Faber A . The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics. Cancer Discov. 2015; 5(5):475-87. PMC: 4727530. DOI: 10.1158/2159-8290.CD-15-0011. View

13.

Srivastava R, Chen Q, Siddiqui I, Sarva K, Shankar S . Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1). Cell Cycle. 2007; 6(23):2953-61. DOI: 10.4161/cc.6.23.4951. View

14.

Anand P, Sundaram C, Jhurani S, Kunnumakkara A, Aggarwal B . Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 2008; 267(1):133-64. DOI: 10.1016/j.canlet.2008.03.025. View

15.

Chang Q, Li Y, White M, Fletcher J, Xiao S . Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res. 2002; 62(21):6035-8. View

16.

Wang L, Ye X, Cai X, Su J, Ma R, Yin X . Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells. Oncotarget. 2015; 6(20):18027-37. PMC: 4627233. DOI: 10.18632/oncotarget.4090. View

17.

Mansoor T, Ramalho R, Luo X, Ramalhete C, Rodrigues C, Ferreira M . Isoflavones as apoptosis inducers in human hepatoma HuH-7 cells. Phytother Res. 2011; 25(12):1819-24. DOI: 10.1002/ptr.3498. View

18.

Isaacs J . Role of androgens in prostatic cancer. Vitam Horm. 1994; 49:433-502. DOI: 10.1016/s0083-6729(08)61152-8. View

19.

Paulraj F, Abas F, Lajis N, Othman I, Hassan S, Naidu R . The Curcumin Analogue 1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one Induces Apoptosis and Downregulates E6 and E7 Oncogene Expression in HPV16 and HPV18-Infected Cervical Cancer Cells. Molecules. 2015; 20(7):11830-60. PMC: 6331910. DOI: 10.3390/molecules200711830. View

20.

Golbert D, Correa-de-Santana E, Ribeiro-Alves M, de Vasconcelos A, Savino W . ITGA6 gene silencing by RNA interference modulates the expression of a large number of cell migration-related genes in human thymic epithelial cells. BMC Genomics. 2014; 14 Suppl 6:S3. PMC: 3909006. DOI: 10.1186/1471-2164-14-S6-S3. View